Addus HomeCare Corp (ADUS)

NASD · Healthcare · Medical Care Facilities · USA

Addus HomeCare Corp is a mid cap company (market value between $2 billion and $10 billion) in the Medical Care Facilities industry.

Addus HomeCare operates three segments—personal care, hospice, and home health—providing in-home services across multiple states. The company serves dual-eligible consumers through agreements with government agencies, managed care organizations, insurers, and private individuals. Its offerings assist elderly and infirm adults with activities of daily living and medical care, allowing them to maintain independence at home.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Addus HomeCare Corp stock.

Our verdict on ADUS

Slightly undervalued: intrinsic value $140.06 per share, market price $121.56, margin of safety 13.2% (as of 2026-11-17).

Discounting its cash flows at 8.9% (average of 3 methods) values the shares at $140.06; the price of $121.56 is 13% below that value, and 77% of that value comes from beyond year five.

ETFs with the most weight in ADUS

17 more funds hold it; the full list is part of the paid plan.

More on ADUS

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than ADUS in Medical Care Facilities

8 more in this industry show a wider margin of safety.

Is ADUS undervalued or overvalued?

ADUS is slightly undervalued (as of the 2026-11-17 close). Discounting its cash flows at 8.9% (average of 3 methods) values the shares at $140.06; the price of $121.56 is 13% below that value, and 77% of that value comes from beyond year five.

What is the intrinsic value of ADUS?

$140.06 per share (as of the 2026-11-17 close), against a market price of $121.56. That is a margin of safety of 13.2%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.